Eli Lilly and Co (XSWX:LLY) E10: CHF8.06 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:LLY Eli Lilly and Co XSWX:LLY
92 GF Score
Price CHF980.00
GF Value CHF1,237.21
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Eli Lilly and Co E10?

Eli Lilly and Co XSWX:LLY 92 E10 is CHF8.06 as of Jun. 2026. GuruFocus rates XSWX:LLY with a GF Score™ of 92/100 and a GF Value™ of CHF1,237.21 (Modestly Undervalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Eli Lilly and Co's adjusted earnings per share data for the three months ended in Jun. 2026 was CHF6.346. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is CHF8.06 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Eli Lilly and Co's average E10 Growth Rate was 42.00% per year. During the past 3 years, the average E10 Growth Rate was 19.10% per year. During the past 5 years, the average E10 Growth Rate was 14.30% per year. During the past 10 years, the average E10 Growth Rate was 10.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Eli Lilly and Co was 19.10% per year. The lowest was -2.70% per year. And the median was 5.90% per year.

As of today (2026-08-26), Eli Lilly and Co's current stock price is CHF980.00. Eli Lilly and Co's E10 for the quarter that ended in Jun. 2026 was CHF8.06. Eli Lilly and Co's Shiller PE Ratio of today is 121.59.

During the past 13 years, the highest Shiller PE Ratio of Eli Lilly and Co was 172.05. The lowest was 23.03. And the median was 55.72.


Eli Lilly and Co  (XSWX:LLY) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Eli Lilly and Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=980.00/8.06
=121.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Eli Lilly and Co was 172.05. The lowest was 23.03. And the median was 55.72.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Eli Lilly and Co E10 Related Terms


Eli Lilly and Co E10 Historical Data

* Premium members only.

The historical data trend for Eli Lilly and Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eli Lilly and Co E10 Chart

Eli Lilly and Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.68 4.64 4.38 5.44 6.53

Eli Lilly and Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.58 5.77 6.53 7.28 8.06

XSWX:LLY vs JNJ, ABBV, MRK: E10 Comparison

For the Drug Manufacturers - General subindustry, Eli Lilly and Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eli Lilly and Co Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eli Lilly and Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Eli Lilly and Co's Shiller PE Ratio falls into.


XSWX:LLY
92GF Score
Eli Lilly and Co XSWX:LLY
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eli Lilly and Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Eli Lilly and Co's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=6.346/333.9520*333.9520
=6.346

Current CPI (Jun. 2026) = 333.9520.

Eli Lilly and Co Quarterly Data

per share eps CPI Adj_EPS
201609 0.710 241.428 0.982
201612 0.715 241.432 0.989
201703 -0.100 243.801 -0.137
201706 0.920 244.955 1.254
201709 0.510 246.819 0.690
201712 -1.559 246.524 -2.112
201803 1.100 249.554 1.472
201806 -0.248 251.989 -0.329
201809 1.084 252.439 1.434
201812 1.056 251.233 1.404
201903 4.312 254.202 5.665
201906 1.423 256.143 1.855
201909 1.357 256.759 1.765
201912 1.535 256.974 1.995
202003 1.535 258.115 1.986
202006 1.475 257.797 1.911
202009 1.217 260.280 1.561
202012 1.966 260.474 2.521
202103 1.385 264.877 1.746
202106 1.389 271.696 1.707
202109 1.126 274.310 1.371
202112 1.667 278.802 1.997
202203 1.952 287.504 2.267
202206 1.019 296.311 1.148
202209 1.567 296.808 1.763
202212 1.900 296.797 2.138
202303 1.379 301.836 1.526
202306 1.756 305.109 1.922
202309 -0.054 307.789 -0.059
202312 2.093 306.746 2.279
202403 2.204 312.332 2.357
202406 2.932 314.175 3.117
202409 0.907 315.301 0.961
202412 4.351 315.605 4.604
202503 2.704 319.799 2.824
202506 5.115 322.561 5.296
202509 4.944 324.800 5.083
202512 5.889 324.054 6.069
202603 6.503 330.213 6.577
202606 6.346 333.952 6.346

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of CHF8.06 mean?
Eli Lilly and Co (XSWX:LLY) has a E10 of CHF8.06 as of Jun. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Eli Lilly and Co and its competitors.
Is Eli Lilly and Co's E10 too high?
Eli Lilly and Co's current E10 is CHF8.06. Overall, Eli Lilly and Co has a GF Score™ of 92/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Eli Lilly and Co's E10 compare to JNJ and ABBV?
Eli Lilly and Co's E10 of CHF8.06 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Eli Lilly and Co and its competitors. Eli Lilly and Co's current E10 is CHF8.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eli Lilly and Co stock overvalued right now?
Based on GuruFocus' analysis, Eli Lilly and Co (XSWX:LLY) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF1,237.21, compared to a current price of CHF980.00 — trading 20.8% below its estimated fair value. The current E10 is CHF8.06. Eli Lilly and Co's overall GF Score™ is 92/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Eli Lilly and Co (XSWX:LLY), the current E10 is CHF8.06 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Eli Lilly and Co (XSWX:LLY) Overvalued in 2026?

Based on GuruFocus' analysis, Eli Lilly and Co stock appears to be undervalued. The current stock price of CHF980.00 is trading 20.8% below its estimated GF Value™ of CHF1,237.21. GuruFocus considers Eli Lilly and Co to be Modestly Undervalued.

Key valuation signals for XSWX:LLY:

  • E10: CHF8.06
  • GF Value™: CHF1,237.21 vs. price of CHF980.00 (20.8% below fair value)
  • GF Score™: 92/100 with 4 warning signs

No single metric tells the full story. See the XSWX:LLY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Eli Lilly and Co Business Description

Address Lilly Corporate Center, Indianapolis, IN, USA, 46285
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
92GF Score

Get the complete analysis for XSWX:LLY

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF980.00
Price
CHF1,237.21
GF Value